These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30676120)

  • 1. Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy.
    Lundgren D; Eklöf V; Palmqvist R; Hultdin J; Karling P
    Scand J Gastroenterol; 2019 Feb; 54(2):152-157. PubMed ID: 30676120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
    Andréasson K; Scheja A; Saxne T; Ohlsson B; Hesselstrand R
    J Intern Med; 2011 Jul; 270(1):50-7. PubMed ID: 21205026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey.
    Kalla R; Boyapati R; Vatn S; Hijos G; Crooks B; Moore GT; Hall V; Lipscomb G; Gomollón F; Jahnsen J; Singh S
    Scand J Gastroenterol; 2018 Dec; 53(12):1437-1442. PubMed ID: 30451040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behçet's disease.
    Kim DH; Park Y; Kim B; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    J Gastroenterol Hepatol; 2017 Mar; 32(3):595-601. PubMed ID: 27521492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
    Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study.
    Motaganahalli S; Beswick L; Con D; van Langenberg DR
    Intern Med J; 2019 Jan; 49(1):94-100. PubMed ID: 29962008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study.
    Hovstadius H; Lundgren D; Karling P
    Inflamm Intest Dis; 2021 May; 6(2):101-108. PubMed ID: 34124181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal calprotectin: current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists.
    Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S
    Intern Med J; 2016 May; 46(5):590-5. PubMed ID: 26946938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis.
    Petryszyn P; Staniak A; Wolosianska A; Ekk-Cierniakowski P
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1306-1312. PubMed ID: 31464777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.
    Poullis A; Foster R; Mendall MA; Shreeve D; Wiener K
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):573-4; author reply 574. PubMed ID: 12702920
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
    McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
    BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
    Amcoff K; Stridsberg M; Lampinen M; Magnuson A; Carlson M; Halfvarson J
    Scand J Gastroenterol; 2017 Mar; 52(3):344-350. PubMed ID: 27881032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral diclofenac intake on faecal calprotectin.
    Rendek Z; Falk M; Grodzinsky E; Wahlin K; Kechagias S; Svernlöv R; Hjortswang H
    Scand J Gastroenterol; 2016 Jan; 51(1):28-32. PubMed ID: 26200803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB; Longlands MG; Wiener K; Shreeve DR
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.